Cargando…

Exploiting tumor cell senescence in anticancer therapy

Cellular senescence is a physiological process of irreversible cell-cycle arrest that contributes to various physiological and pathological processes of aging. Whereas replicative senescence is associated with telomere attrition after repeated cell division, stress-induced premature senescence occur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Minyoung, Lee, Jae-Seon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Biochemistry and Molecular Biology 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163898/ https://www.ncbi.nlm.nih.gov/pubmed/24411464 http://dx.doi.org/10.5483/BMBRep.2014.47.2.005

Ejemplares similares

Senescence of Tumor Cells in Anticancer Therapy—Beneficial and Detrimental Effects
por: Piskorz, Wiktoria Monika, et al.
Publicado: (2022)

Targeting senescence as an anticancer therapy
por: Bousset, Laura, et al.
Publicado: (2022)

Role of Senescence in Tumorigenesis and Anticancer Therapy
por: Stoczynska-Fidelus, Ewelina, et al.
Publicado: (2022)

Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
por: Panebianco, Concetta, et al.
Publicado: (2018)

Cellular senescence: a promising strategy for cancer therapy
por: Lee, Seongju, et al.
Publicado: (2019)

The Potential of Senescence as a Target for Developing Anticancer Therapy
por: Jo, Hyein, et al.
Publicado: (2023)

Memory NK Cell Features Exploitable in Anticancer Immunotherapy
por: Capuano, Cristina, et al.
Publicado: (2019)

COVID-19 and systemic anticancer therapy: exploiting uncertainty
por: Gelderblom, Hans, et al.
Publicado: (2021)

Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy
por: Prasanna, Pataje G, et al.
Publicado: (2021)

Mycoplasma exploits mammalian tunneling nanotubes for cell-to-cell dissemination
por: Kim, Bong-Woo, et al.
Publicado: (2019)

Correction to: Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy
Publicado: (2022)

Targeting anticancer drug-induced senescence in glioblastoma therapy
por: Tomicic, Maja T., et al.
Publicado: (2018)

Factors and Pathways Modulating Endothelial Cell Senescence in Vascular Aging
por: Hwang, Hyun Jung, et al.
Publicado: (2022)

Possibility of inducing tumor cell senescence during therapy
por: Wang, Guohui, et al.
Publicado: (2021)

Exploiting Human NK Cells in Tumor Therapy
por: Vacca, Paola, et al.
Publicado: (2020)

Exploiting B Cell Transfer for Cancer Therapy: Engineered B Cells to Eradicate Tumors
por: Page, Audrey, et al.
Publicado: (2021)

Involvement of Klotho, TNF-α and ADAMs in radiation-induced senescence of renal epithelial cells
por: Kim, Da Yeon, et al.
Publicado: (2021)

Mechanisms of RNA and Protein Quality Control and Their Roles in Cellular Senescence and Age-Related Diseases
por: Kang, Donghee, et al.
Publicado: (2022)

Senescent cells: A new Achilles’ heel to exploit for cancer medicine?
por: Zhang, Boyi, et al.
Publicado: (2018)

Recent Advances in the Development of TGF-β Signaling Inhibitors for Anticancer Therapy
por: Lee, Ho-Jae
Publicado: (2020)

Exploiting the Nucleotide Substrate Specificity of Repair DNA Polymerases To Develop Novel Anticancer Agents
por: Crespan, Emmanuele, et al.
Publicado: (2011)

The interaction of anticancer therapies with tumor-associated macrophages
por: Mantovani, Alberto, et al.
Publicado: (2015)

Exploiting vulnerabilities of cancer by targeting nuclear receptors of stromal cells in tumor microenvironment
por: Cheng, Hong Sheng, et al.
Publicado: (2019)

Regulatory T Cells in Tumor Microenvironment and Approach for Anticancer Immunotherapy
por: Kim, Jung-Ho, et al.
Publicado: (2020)

Targeting senescent cells and tumor therapy (Review)
por: Wang, Zehua, et al.
Publicado: (2020)

Long Noncoding RNAs and RNA-Binding Proteins in Oxidative Stress, Cellular Senescence, and Age-Related Diseases
por: Kim, Chongtae, et al.
Publicado: (2017)

Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy
por: Li, Xian-Miao, et al.
Publicado: (2023)

Exploiting NK Cell Surveillance Pathways for Cancer Therapy
por: Barrow, Alexander David, et al.
Publicado: (2019)

Senescence and tumor suppression
por: Hinds, Philip, et al.
Publicado: (2017)

Cellular senescence enhances adaptive anticancer immunosurveillance
por: Marin, Ines, et al.
Publicado: (2022)

Exploiting Genetic Interference for Antiviral Therapy
por: Tanner, Elizabeth J., et al.
Publicado: (2016)

Molecular targeted therapy for anticancer treatment
por: Min, Hye-Young, et al.
Publicado: (2022)

Exploiting Lipid and Polymer Nanocarriers to Improve the Anticancer Sonodynamic Activity of Chlorophyll
por: Bosca, Federica, et al.
Publicado: (2020)

Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence
por: Fleury, Hubert, et al.
Publicado: (2019)

Endothelial-to-mesenchymal transition in anticancer therapy and normal tissue damage
por: Choi, Kyu Jin, et al.
Publicado: (2020)

Senescent tumor cells building three-dimensional tumor clusters
por: Lee, Hyun-Gyu, et al.
Publicado: (2018)

A Pilot Prospective Study of Refractory Solid Tumor Patients for NGS-Based Targeted Anticancer Therapy()()
por: Seol, Young Mi, et al.
Publicado: (2018)

Cellular senescence, aging, and age-related disease: Special issue of BMB Reports in 2019
por: Lee, Jae-Seon
Publicado: (2019)

The Dynamic Process and Its Dual Effects on Tumors of Therapy-Induced Senescence
por: Liao, Chenxi, et al.
Publicado: (2020)

Pseudomonas aeruginosa Transmigrates at Epithelial Cell-Cell Junctions, Exploiting Sites of Cell Division and Senescent Cell Extrusion
por: Golovkine, Guillaume, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3kqn4i3llkj29lra4jkuubjtbt